Eko Low Ejection Fraction Tool (ELEFT) vs Us2.v2

Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes during routine physical exams, providing AI-powered low ejection fraction detection in approximately 15 seconds. Its primary clinical application is aiding in the early identification of heart failure risk as a non-invasive screening tool. Us2.v2 automates echocardiogram interpretation post-acquisition, delivering a complete structured echo report with measurements, disease detection, and clinical findings. It aims to reduce reporting time by up to 70% and increase daily scan throughput for comprehensive diagnostic analysis.

ELEFT is a cloud-based software integrated with Eko digital stethoscopes, with data processing and storage occurring in the cloud. The provided information does not detail direct integration capabilities with existing EHR, PACS, or CVIS systems beyond its connection to the SENSORAu2122 platform. Us2.v2 offers seamless integration with existing PACS, CVIS, or EMR systems, supporting both HL7 and DICOM SR standards. This allows for automated delivery of structured echo reports directly into a physician's existing imaging and health record infrastructure.

ELEFT provides AI-powered low ejection fraction detection, aiding in the early identification of heart failure risk. Clinical validation showed a sensitivity of 74.7% and specificity of 77.5% for LVEF <40%. Us2.v2 delivers a complete structured echo report with measurements, disease detection, and clinical findings, including automated detection of cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease. It features guideline-adherent and explainable AI with transparent visual overlays and editable outputs.

ELEFT is designed for Cardiology, Family Medicine, and Internal Medicine, focusing on the early detection of low ejection fraction (LVEF u2264 40%) as a key indicator of heart failure during routine physical exams. It serves as a non-invasive screening tool across these specialties. Us2.v2 is primarily designed for Cardiology, offering automated interpretation for a broader range of conditions including cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease. It provides comprehensive diagnostic analysis for echocardiograms.

ELEFT provides results in approximately 15 seconds during a routine physical exam, suggesting immediate value in identifying heart failure risk at the point of care. Its impact on throughput comes from integrating into an existing, quick screening step. Us2.v2 can reduce echocardiogram reporting time by up to 70% and increase daily scan throughput by automating interpretation and report generation. This allows for rapid value realization through improved efficiency and increased capacity for echo analysis.

ELEFT is part of Eko's SENSORAu2122 platform, an enterprise solution, suggesting it is designed with multi-site deployments in mind. As a cloud-based software, it likely offers centralized management for multiple locations. Us2.v2 offers both cloud and on-premise deployment options, providing flexibility for large healthcare systems to choose the model best suited for their multi-site infrastructure. Custom pricing based on deployment options also supports tailored multi-site rollouts.